Identity
Kisspeptin-10 is a kisspeptin isoform that stimulates the reproductive hormone axis.
Selected study only; not a complete clinical review.
Peptide library
Kisspeptin-10
Your guide to this compound.
Mechanism illustrationEnlarge
Evidence in perspective
Small, single-blind IV hormone experiments establish a gonadotropin response. A biochemical response alone does not demonstrate improved live birth, libido or treatment of an endocrine disorder.
About this assessment
Existing source snapshot critically reassessed.
Based on the selected source scope described in this profile, often an indexed abstract. Full methods and clinician sign-off remain pending; no systematic-review claim.
Editorial assessment · 2026-09-07
Who was studied
Healthy men; small single-blind intravenous physiological study.
What the sources found
Infusion stimulated gonadotropin secretion. Hormonal response does not establish fertility or libido treatment benefit.
Regulatory scope
Current authorization for the exact product and jurisdiction was not independently checked in this snapshot. A clinical trial is not marketing authorization.
What remains unknown
Selected indexed primary-study abstract reviewed. Full methods, bias, all safety outcomes, product stability, current jurisdictional authorization and a comprehensive literature search remain outstanding. This is not a complete clinical review.
How it works
Kisspeptin-10 is a kisspeptin isoform that stimulates the reproductive hormone axis.
The study-specific findings below distinguish biological activity from demonstrated treatment benefit.
Limited clinical evidence
The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.
Reported adverse effects
- This short experiment cannot define long-term endocrine or reproductive safety.
Selected study only; not a complete clinical review.
Contraindications
- A complete contraindication and interaction review remains outstanding.
Limited clinical evidence
The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.
Sources used for this snapshot
Claim-by-claim evidence
Benefits
Infusion stimulated gonadotropin secretion. Hormonal response does not establish fertility or libido treatment benefit.
Selected study only; not a complete clinical review.
Adverseeffects
This short experiment cannot define long-term endocrine or reproductive safety.
Selected study only; not a complete clinical review.
References
Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men. 2015.
PMID: 26089302
Catalog review date: Sep 7, 2026. This date alone does not establish independent clinical review.